Digital asset holdings rise as Exodus advances payments strategy OMAHA, Neb., April 08, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus” or “the company”), a leading self-custodial cryptocurrency platform, today announced updated digital asset holdings, user metrics, and exchange provider processed volume metrics, as of March 31, 2026. Exodus grew its digital asset treasury across all three core holdings in March and continued to advance its payments infrastructure, even as industry-wide crypto trading volumes fell to nineteen-month lows. Exodus CFO James Gernetzke remarked: “March was one of the slowest trading months the industry has seen in over a year, and our volume reflects that. It’s exactly why building a complete payments experience––through Exodus Pay for our customers, and across...

Stockholm, 8 April 2026 – Virtune AB (Publ) (“Virtune”) today announces that it has completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm, Nasdaq Helsinki and Xetra (ISIN code SE0023260716). In addition to the Virtune Crypto Altcoin Index ETP, Virtune’s product portfolio includes: Virtune Bitcoin ETPVirtune Staked Ethereum ETPVirtune Stellar ETPVirtune Staked Solana ETPVirtune Staked Polkadot ETPVirtune XRP ETPVirtune Avalanche ETPVirtune Litecoin ETPVirtune Chainlink ETPVirtune Arbitrum ETPVirtune Polygon ETPVirtune Staked Cardano ETPVirtune Crypto Top 10 Index ETP SEKVirtune Crypto Top 10 Index ETP EURVirtune Bitcoin Prime ETPVirtune Coinbase 50 Index ETPVirtune Staked Near ETPVirtune Sui ETPVirtune Stablecoin Index ETPVirtune Bittensor ETPVirtune BNB ETP Index allocation as...

Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to progress Phase 1 to the next dose level of 130mCi in patients with HER2+ advanced solid tumors SYDNEY, April 08, 2026 (GLOBE NEWSWIRE) — Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that it has received a positive recommendation from the Data Safety and Monitoring Committee (DSMC) to advance its clinical-stage radiotherapeutic asset, 177Lu-RAD202 (RAD202), to the next dose level of 130mCi in the Phase 1 ‘HEAT’ clinical trial in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive advanced solid tumors1. The DSMC is a multidisciplinary...

CHANTILLY, Va., April 08, 2026 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN), a leading provider of national security and global infrastructure solutions, today announced the unification of its aviation capabilities into a single, integrated North American Aviation organization. This strategic alignment strengthens the company’s One Parsons approach and enhances its ability to deliver technologically enabled aviation solutions quickly at scale, unlocking value for shareholders and customers, and accelerating the company’s momentum and ability to further cross-sell opportunities across the rapidly evolving global aviation market. Parsons’ extensive aviation experience spans more than 450 airports worldwide, decades of federal aviation modernization, and major commercial airport programs across North America and the Middle East....

BEIJING, April 08, 2026 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing around RMB27.3 million to repurchase 603,724 ordinary shares on April 7. Year-to-date in 2026, the Company has deployed nearly RMB721 million toward share repurchases. This move underscores the Company’s ongoing commitment to shareholder returns. CONTACT: CONTACT: PIACENTE·FINANCIAL COMMUNICATIONS kanzhun@tpg-ir.com

PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched Isosorbide Mononitrate Tablet USP, 10 mg and 20 mg. ANI’s Isosorbide Mononitrate Tablet USP is the generic version of the reference listed drug (RLD) Monoket®. “We are pleased to announce FDA approval and launch of Isosorbide Mononitrate Tablet USP, which highlights our efforts to bring limited-competition products to market and ensure that our high-quality products are readily accessible to our customers and patients in need,” stated Nikhil Lalwani, President and Chief Executive Officer of ANI. “This launch reinforces the strength of our R&D capabilities...

PHOENIX, April 08, 2026 (GLOBE NEWSWIRE) — Reliance, Inc. (NYSE:RS) announced today that it will report first quarter 2026 financial results for the period ended March 31, 2026, on Wednesday, April 22, 2026, after the market closes. Reliance management will host a conference call on Thursday, April 23, 2026, at 11:00 a.m. Eastern Time. The call will be broadcast live over the Internet hosted on the Investors section of the Company’s website at reliance.com. Reliance, Inc. First Quarter 2026 Conference Call DetailsDATE:       Thursday, April 23, 2026         TIME:       8:00 a.m. Pacific Time10:00 a.m. Central Time11:00 a.m. Eastern Time         DIAL-IN:       (877) 407-0792 (U.S. and Canada)(201) 689-8263 (International)         CONFERENCE ID:       13759369         WEBCAST:       https://viavid.webcasts.com/starthere.jsp?ei=1756570&tp_key=f18bbb31dc           For...

VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) reports first quarter 2026 production of 1,875,375 silver ounces (“oz”), 11,740 gold oz, and in combination with base metals, a silver equivalent (1) (“AgEq”) production of 3.3 million oz. All dollar amounts are in US dollars ($). “We are pleased to report robust production for the first quarter of 2026, highlighted by steady performance at Terronera, which delivered improved grades and recoveries without any significant shutdowns,” commented Dan Dickson, Chief Executive Officer. “Guanaceví continued to perform consistently, and Kolpa not only enhanced its processing capabilities despite adverse weather but is now set to increase production to 2,500 tonnes per day for the quarters ahead....

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) — Brookfield Asset Management Ltd. today announced it will host its first quarter 2026 conference call and webcast on Friday, May 8, 2026, at 10:00 a.m. ET. Results will be released that morning prior to 7:00 a.m. ET and will be available on our website at www.bam.brookfield.com/news-events/press-releases. Participants can join by conference call or webcast: Conference CallPlease pre-register by conference call:https://register-conf.media-server.com/register/BI4a9ba8996eec4112a6842d2dbf312077 Upon registering, you will be emailed a dial-in number, and unique PIN. This process will bypass the operator and avoid the queue.WebcastPlease join and register by webcast: https://edge.media-server.com/mmc/p/wptdyzxuAbout Brookfield Asset Management Brookfield Asset Management Ltd. (NYSE:...